Research database
SVF Research Library
Search 52,792 real PubMed studies on SVF and adipose-derived stem cells — 9 matching records.
9 results — page 1 of 1
- Level CProspective StudyEurope PMC
Nonsurgical Aesthetic Treatment of the Face and Neck in GLP-1 Receptor Agonist Weight Loss Patients: Experience-Based Considerations
Prospective Study on Skin Aging, published in Aesthet Surg J Open Forum (2026) — summary generated from the PubMed abstract.
- 2026
Aesthet Surg J Open Forum3 citations - Level ASystematic ReviewPubMed
Do GLP-1 Receptor Agonists Sabotage Fat Grafts? : A Scoping Review of GLP-1 Receptor Agonist Effects on Adipocyte Biology and Implications for Autologous Fat Transfer.
Systematic Review on Face & Skin, published in Aesthet Surg J (2026) — summary generated from the PubMed abstract.
- 2026
Aesthet Surg J - Level DNarrative ReviewEurope PMC
Benefit-Risk Assessment of GLP-1 Receptor Agonists: Implications for Dermatologists and Plastic Surgeons
Narrative Review on Type 2 Diabetes, Chronic Wound, Chronic Inflammation, Immune Modulation, published in Dermatol Ther (Heidelb) (2025) — summary generated from the PubMed abstract.
- 2025
Dermatol Ther (Heidelb) - Level BClinical TrialEurope PMC
Alopecia as an Emerging Adverse Effect Associated With Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists for Weight Loss: A Scoping Review
Clinical Trial on Hair Loss, published in Cureus (2025) — summary generated from the PubMed abstract.
- 2025
Cureus1 citations - Level DNarrative ReviewEurope PMC
Functional and Aesthetic Periorbital, Ocular Adnexal and Ocular Surface Changes Linked to GLP-1 Receptor Agonists
Narrative Review on Type 2 Diabetes, published in J Clin Med (2025) — summary generated from the PubMed abstract.
- 2025
J Clin Med1 citations - Level CProspective StudyEurope PMC
The dual GLP-1/glucagon receptor agonist G49 mimics bariatric surgery effects by inducing metabolic rewiring and inter-organ crosstalk
Prospective Study on Type 2 Diabetes, published in Nat Commun (2024) — summary generated from the PubMed abstract.
- 2024
Nat Commun13 citations - Level DNarrative ReviewEurope PMC
Novel Insights into the Roles and Mechanisms of GLP-1 Receptor Agonists against Aging-Related Diseases
Narrative Review on Type 2 Diabetes, Chronic Inflammation, published in Aging Dis (2022) — summary generated from the PubMed abstract.
- 2022
Aging Dis57 citations - Level DAnimal StudyEurope PMC
The GLP-1 receptor agonist, liraglutide, fails to slow disease progression in SOD1 G93A and TDP-43 Q331K transgenic mouse models of ALS
Animal Study on Neuroinflammation, published in Sci Rep (2021) — summary generated from the PubMed abstract.
- 2021
Sci Rep18 citations - Level DAnimal StudyPubMed
Effect of combined therapy of mesenchymal stem cells with GLP-1 receptor agonist, exenatide, on early-onset nephropathy induced in diabetic rats.
Animal Study on Type 2 Diabetes, Chronic Kidney Disease, published in Eur J Pharmacol (2020) — summary generated from the PubMed abstract.
- 2020
Eur J Pharmacol
In-depth reviewed studies (full Thai translation)
Evidence system- Level ARandomized Controlled Trial
Cell-based versus corticosteroid injections for knee pain in osteoarthritis: a randomized phase 3 trial
A multicentre randomized trial in 480 knee osteoarthritis patients comparing SVF, BMAC and umbilical cord MSCs against corticosteroid injection. At 12 months no cell product outperformed the steroid control.
- 2023
- United States
- n = 480
- Level AMeta-analysis
Intra-articular Injection of Autologous Adipose-Derived Stem Cells or Stromal Vascular Fractions: Are They Effective for Patients With Knee Osteoarthritis? A Systematic Review With Meta-analysis of Randomized Controlled Trials
Pooled five RCTs comparing ADSC/SVF injection with placebo or hyaluronic acid, finding significant pain and function improvement at 6 and 12 months.
- 2023
- South Korea
- Level AMeta-analysis
Rapid-acting pain relief in knee osteoarthritis: autologous-cultured adipose-derived mesenchymal stem cells outperform stromal vascular fraction: a systematic review and meta-analysis
Analysed 31 studies with 1,406 patients: cultured ADMSCs reduced pain from month 3, whereas SVF reached significance only at 12 months.
- 2024
- South Korea
- n = 1406